UPM participated in the ‘Digital Oncology: supporting clinical trials with biomedical sensors and wearables in cancer treatment and post-cancer follow up’ leading this mini symposium, within the 46th annual IEE EMBS international conference (15-19 July, orlando, USA). In particular contribution on the discussion of these two slots:

• • “Designing protocols and data analysis for discovering predictors and risk factors in chronic diseases” presenting study design and challenges addressed.

• • “Benefits and opportunities of RWD through wearables and sensors for innovative cancer treatment and survivorship methods and tools in the context of clinical trials” showcasing the technology solution developed within the clinical trial rationale.

During the congress, BD4QoL promoted the project results showing the relevant oncology research-specific considerations regarding how patient health status and routinely collected data can support the delivery of health care, as well as provide critical evidence for improving their quality of life.